Please use this identifier to cite or link to this item:
|Title:||Growth, motility and resistance to oxidative stress of the melioidosis pathogen Burkholderia pseudomallei are enhanced by epinephrine|
Mark P. Stevens
Chulabhorn Research Institute
University of Edinburgh, Roslin Institute
|Keywords:||Immunology and Microbiology;Medicine|
|Citation:||Pathogens and Disease. Vol.72, No.1 (2014), 24-31|
|Abstract:||© 2014 Federation of European Microbiological Societies. Burkholderia pseudomallei causes melioidosis, a severe invasive disease endemic in South-East Asia and Northern Australia. Bacterial pathogens of several genera have been reported to be able to sense and respond to the stress-related catecholamine hormone epinephrine. Here, we report that epinephrine induces growth of B. pseudomallei in minimal serum-rich medium and heat-inactivated whole human serum and enhances bacterial motility, transcription of flagellar genes and flagellin synthesis. The effect of epinephrine on motility, but not bacterial growth, could be partially reversed by the alpha-adrenergic receptor antagonist phentolamine. Epinephrine also altered the transcription of iron-regulated genes encoding superoxide dismutase (sodB) and the malleobactin receptor (fmtA). Consistent with induction of sodB expression, epinephrine-treated B. pseudomallei exhibited increased resistance to superoxide. Epinephrine treatment did not stimulate Type III secretion via the virulence-associated Bsa apparatus or the ability of B. pseudomallei to invade epithelial cells in culture. This study provides the first evidence that epinephrine, a hormone released from the host under stress and upon therapy, can affect B. pseudomallei virulence-associated properties.|
|Appears in Collections:||Scopus 2011-2015|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.